Vimseltinib

DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10) . (In Vitro) :DCC-3014 has anti-cancer and anti-proliferative activities.

Product Specifications

CAS Number

1628606-05-2

Product Name Alternative

DCC-3014

Purity

>98% (HPLC)

Solubility

In Vitro: DMSO : 50 mg/mL (115.88 mM)

Smiles

CC (C) Nc1ncc (-c2ccc (Oc3ccnc (c3) -c3cnn (C) c3) c (C) n2) c (=O) n1C

Molecular Formula

C23H25N7O2

Molecular Weight

431.5

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-72311H 0.1 mL

Mouse Monoclonal Bmf Antibody (OTI6F3) [HRP]

View Details

TA808345S 30 µL

CAMK2B Mouse Monoclonal Antibody [Clone ID: OTI8D9]

View Details

BAA02246-01 0.5 g

Bentranil

View Details

BAA02246-02 5 g

Bentranil

View Details

SR500171 1 Kit

Slc14a2 Rat siRNA Oligo Duplex (Locus ID 54302)

View Details

bsm-62137R-BF488 100 µL

RAP1A/1B Recombinant Antibody, AbBy Fluor™ 488 Conjugated

View Details